Latest total liabilities for SMDPY: $440B.
Get informed when a big investor buys or sells
+ FollowLatest change versus the prior comparable period (same company).
Sumitomo Pharma , Ltd. (SMDPY) currently reports a total liabilities of $440B as of June 2026. That compares with $560B in the prior-year period — down 21.7% year over year. Use the charts on this page to explore Sumitomo Pharma , Ltd.'s total liabilities history and peer comparisons.
Sumitomo Pharma , Ltd.'s total liabilities decreased from $560B to $440B — a 21.7% year-over-year decrease (period ending June 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.
Sumitomo Pharma , Ltd. reported $440B in total liabilities as of June 2026. That compares with $560B in the prior-year period — down 21.7% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.
Start with the current total liabilities of $440B, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Sumitomo Pharma , Ltd., and consider following SMDPY for alerts when major investors trade the stock.